Skip to content

Clinical trials

Phase 2 Migraine Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 2 Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20041
20056
20068
20078
200811
200910
20102
20112
20127
20132
20146
20151
20166
201712
20185
20195
20204
20218
20223
20233
20247
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91
Terminated13
Recruiting12
Unknown status11
Withdrawn6
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
Alexza Pharmaceuticals, Inc.5
Merck Sharp & Dohme LLC5
Allodynic Therapeutics, Inc4
Amgen3
GlaxoSmithKline3
St. Olavs Hospital3
Universidade Federal de Pernambuco3
AEON Biopharma, Inc.2
Allergan2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders136
Headache35
Migraine with Aura10
Epilepsy7
Migraine without Aura6
Pain6
Foramen Ovale, Patent3
Marijuana Abuse3
Nausea3
Facial Pain2

Trials

Showing 76 to 100 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.